Role of protein tyrosine kinase on regulation of trabecular meshwork and ciliary muscle contractility

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 6, 1998, Pages 1012-1020

  Wiederholt, Michael ^a   Groth, Juliane ^a   Strauss, Olaf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DIAMINO N [[1 (1 OXOTRIDECYL) 2 PIPERIDYL]METHYL]HEXANAMIDE; CARBACHOL; CHELERYTHRINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GENISTEIN; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; TYRPHOSTIN;

ANIMAL TISSUE; ARTICLE; CATTLE; CILIARY MUSCLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; TRABECULAR MESHWORK;

ANIMALS; CATTLE; CILIARY BODY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; ISOMETRIC CONTRACTION; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; TRABECULAR MESHWORK;

EID: 0031958393     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Walaas SI, Greengard P. Protein phosphorylation and neuronal function. Pharmacol Rev. 1991;43:299-349.
2. Glenney JR. Tyrosine-phosphorylated proteins: mediators of signal transduction from the tyrosine kinases. Biochim Biophys Acta 1992;1134:113-127.
3. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature. 1993;361:315-325.
4. Pawson T. Protein-tyrosine kinases. Getting down to specifics. Nature. 1995;373:477-478.
5. Muramatsu I, Itoh H, Lederis K, Hollenberg MD. Distinctive actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: differential inhibition by indomethacin. J Pharmacol Exp Ther. 1988;245:625-631.
6. Yamaguchi K, Lederis K, Hollenberg MD. Contraction of porcine ocular ciliary muscle by epidermal growth factor-urogastrone. Eur J Pharmacol. 1990;191:245-251.
7. Sauro MD, Thomas B. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s). J Pharmacol Exp Ther. 1993;267:1119-1125.
8. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun. 1993;190:968-974.
9. Hollenberg MD. The acute actions of growth factors in smooth muscle systems. Life Sci. 1994;54:223-235.
10. 2+-free contraction of uterine smooth muscle of the rat. Gen Pharmacol. 1994;25:1673-1677.
11. 2+ sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol. 1994;72:1434-1439.
12. Semenchuk LA, Di Salvo J. Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells. FEBS Lett. 1995;370:127-130.
13. Levitzki A. Signal-transduction therapy. A novel approach to disease management. Eur J Biochem. 1994;226:1-13.
14. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 1995;267:1782-1788.
15. Wiederholt M, Dörschner N, Groth J. Effect of diuretics, channel modulators, and signal interceptors on contractility of the trabecular meshwork. Ophthalmologica. 1997;211:153-161.
16. Wiederholt M, Stumpff F. The trabecular meshwork and aqueous humor reabsorption. In: Civan MM, ed. Current Topics in Membranes. The Eye's Aqueous Humor From Secretion to Glaucoma. Vol. 45. San Diego: Academic Press; 1998:163-202.
17. Wiederholt M, Bielka S, Schweig F, Lütjen-Drecoll E, Lepple-Wienhues A. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp Eye Res. 1995;61:223-234.
18. Lepple-Wienhues A, Stahl F, Wiederholt M. Differential smooth muscle-like contractile properties of trabecular meshwork and ciliary muscle. Exp Eye Res. 1991;53:33-38.
19. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem. 1987;262: 5592-5595.
20. Wiederholt M, Sturm A, Lepple-Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci. 1994;35:2515-2520.
21. Wiederholt M, Schäfer R, Wagner LJ, Lepple-Wienhues A. Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents. Ger J Ophthalmol. 1996; 5:146-153.
22. Herbert JM, Augereau JM, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993-999.
23. Sullivan JP, Connor JR, Tiffany C, Shearer BG, Burch RM. NPC 15437 interacts with the Cl domain kinase C. An analysis using mutant PKC constructs. FEBS Lett. 1991;285:120-123.
24. Hidaka H, Inagiki M, Kawamoto S, Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 1984;23:5036-5041.
25. Posner BI, Faure R, Burgess JW, et al. Peroxovanadium compounds. J Biol Chem. 1994;269:4596-4604.
26. Shimokado K, Umezawa K, Ogata J. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells. Exp Cell Res. 1995;220:266-273.
27. Hadcock JR, Port JD, Gelman MS, Malbon CC. Cross-talk between tyrosine kinase and G-protein-linked receptors. J Biol. Chem. 1992;267:26017-26022.
28. 1 muscarinic acetylcholine receptor. Cell. 1993;75:1145-1156.
29. Wilson GF, Kaczmarek LK. Mode-switching of voltage-gated cation channel is mediated by a protein kinase A-regulated tyrosine phosphatase. Nature. 1993;366:433-438.
30. Holmes TC, Fadool DA, Levitan IB. Tyrosine phosphorylation of the Kv.1.3 potassium channel. J Neurosci. 1996;16:1581-1590.
31. Hopfield JF, Tank DW, Greengard P, Huganir RL. Functional modulation of the nicotinic acetylcholine receptor by tyrosine phosphorylation. Nature. 1988;336:667-680.
32. Wang YT, Salter MW. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature. 1994;369:233-235.
33. Gallizzi JP, Qar J, Fosset M, Van Renterghem C, Lazdunski M. Regulation of calcium channels in aortic muscle cells by protein kinase C activators (diacylglycerol and phorbolesters) and peptides (vasopressin and bombesin) that stimulate phosphoinositide breakdown. J Biol Chem. 1987;262:6947-6950.
34. 2+ channel currents in vascular smooth muscle cells: involvement of PKC and PKA. FASEB J. 1996;10:1310-1317.
35. Strauss O, Mergler S, Wiederholt W. Regulation of L-type calcium channels by protein tyrosine kinase (PTK) and protein kinase C (PKC) in cultured rat and human retinal pigment epithelial cells. FASEB J. 1997;11:859-867.
36. Wijetunge S, Aalkjaer C, Schachter M, Hughes AD. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun. 1992;189:1620-1623.
37. + currents by tyrosine kinase inhibitors genistein and ST 638. Circ Res. 1995;76:310-316.
38. Minami K, Fukuzawa K, Inoue I. Regulation of a non-selective cation channel of cultured porcine coronary artery smooth muscle cells by tyrosine kinase. Pflugers Arch. 1994;426:254-257.
39. Stumpff F, Strauss O, Boxberger M, Wiederholt M. Characterization of maxi-K-channels in trabecular meshwork and their regulation by cGMP. Invest Ophthalmol Vis Sci. 1997;38:1883-1892.
40. Stumpff F, Que Y, Boxberger M, Strauss O, Wiederholt M. Tyrosine kinase inhibitors relax trabecular meshwork cells via activation of maxi-K channels [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S2211. Abstract nr. B68.
41. Wordinger RJ, Clark AF, Agarwal R, et al. Cultured human trabecular meshwork cells express functional growth factor receptors [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38:S562. Abstract nr. 2614.
42. Rege P, Zhou L, Yue B. Tyrosine phosphorylation in trabecular meshwork cells upon adherence to fibronectin [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4):S564. Abstract nr. 2624.
43. Farooki AZ, Skinner LL, Epstein DL, O'Brien ET. Tyrosine kinase inhibitors specifically disrupt either cell-cell junctions or actin stress fibers in endothelial and trabecular meshwork cells [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4):S817. Abstract nr. 3801.
44. Tian B, Gabelt BT, Hubbard WC, Geiger B, Kaufman PL. Effects of protein kinase inhibitors on trabecular and total outflow facility in monkeys [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4): S812. Abstract nr. 3778.
45. Bilder GE, Krawiec JA, McVety K, et al. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am J Physiol. 1991;260:C721-C730.
46. Hayashi A, Weinberger AWA, Kim HC, Juan E. Genistein, a protein tyrosine kinase inhibitor, ameliorates retinal degeneration after ischemia-reperfusion injury in rat. Invest Ophthalmol Vis Sci. 1997;38:1193-1202.